| HGNC Family | Tumor necrosis factor receptor superfamily (TNFRSF) |
| Name | tumor necrosis factor receptor superfamily, member 25 |
| Description | The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed preferentially in the tissues enriched in lymphocytes, and it may play a role in regulating lymphocyte homeostasis. This receptor has been shown to stimulate NF-kappa B activity and regulate cell apoptosis. The signal transduction of this receptor is mediated by various death domain containing adaptor proteins. Knockout studies in mice suggested the role of this gene in the removal of self-reactive T cells in the thymus. Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported, most of which are potentially secreted molecules. The alternative splicing of this gene in B and T cells encounters a programmed change upon T-cell activation, which predominantly produces full-length, membrane bound isoforms, and is thought to be involved in controlling lymphocyte proliferation induced by T-cell activation. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nTNFRSF25—commonly known as death receptor 3 (DR3)—functions as a key immunomodulatory receptor whose engagement by its ligand TL1A orchestrates diverse inflammatory responses. In the immune compartment, DR3 is expressed on multiple lymphocyte subsets including memory CD4⁺ T cells, innate lymphoid cells, and natural killer cells. Its activation enhances T helper 2 effector responses that drive allergic lung inflammation, promotes Th17 differentiation in rheumatoid arthritis, and bolsters innate cytokine output from group 3 innate lymphoid cells, while simultaneously expanding regulatory T cells that temper overt immune activation. Aberrant DR3 expression is also observed in inflammatory conditions such as psoriasis, preeclampsia, kidney transplant rejection, and in barrier tissues where cells coexpress DR3 together with IL‑18 receptors, thereby contributing to antigen‐independent innate responses."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its immunoregulatory roles, DR3 signaling critically governs cell fate by dictating pro-survival versus death responses. In hematopoietic and cancer cell models, engagement of DR3 by TL1A induces the assembly of a receptor complex that triggers NF‑κB activation and upregulation of anti‑apoptotic proteins; yet under certain conditions, DR3 signaling also promotes caspase‐dependent apoptosis and, intriguingly, can induce necroptosis via RIP1/RIP3 pathways. These cell death mechanisms have been linked to modulation of cancer cell migration and survival in colon and breast carcinomas, with altered DR3 expression or even gene duplication events being associated with autoimmune susceptibility."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "13", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its well‐documented immunological and apoptotic roles, TNFRSF25 signaling exerts significant functions in non‑immune tissues that influence tissue remodeling and homeostasis. In the bone microenvironment, DR3 activity modulates osteoclast formation and osteoblast differentiation, thereby impacting chemokine release, matrix metalloproteinase activity, and bone mineral apposition—factors that contribute to the pathogenesis of inflammatory arthritis and osteoporosis. DR3 is also implicated in endothelial regulation through its ligand VEGI/TL1A, which restricts angiogenesis, and in tissues such as the aged bladder and leukemic cells where DR3 expression correlates with altered proliferation and inflammatory processes. These multifaceted actions highlight the therapeutic promise of targeting the TL1A/DR3 axis in a spectrum of inflammatory, degenerative, and neoplastic disorders."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "28"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Lei Fang, Becky Adkins, Vadim Deyev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20072528"}], "href": "https://doi.org/10.1084/jem.20072528"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18411341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18411341"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Giorgos Bamias, Kostas Evangelou, Theognosia Vergou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Dermatol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1600-0625.2011.01304.x"}], "href": "https://doi.org/10.1111/j.1600-0625.2011.01304.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21672030"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21672030"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Mi H Park, Min J Song, Min-Chul Cho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2567.2011.03513.x"}], "href": "https://doi.org/10.1111/j.1365-2567.2011.03513.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22043900"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22043900"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jingyu Li, Wenli Shi, Hanxiao Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-019-11304-8"}], "href": "https://doi.org/10.1038/s41467-019-11304-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31358760"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31358760"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "P Holmkvist, K Roepstorff, H Uronen-Hansson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A major population of mucosal memory CD4+ T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mucosal Immunol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/mi.2014.87"}], "href": "https://doi.org/10.1038/mi.2014.87"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25269704"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25269704"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jagadeesh Bayry "}, {"type": "b", "children": [{"type": "t", "text": "Immunology: TL1A in the inflammatory network in autoimmune diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Rev Rheumatol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nrrheum.2009.263"}], "href": "https://doi.org/10.1038/nrrheum.2009.263"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20125169"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20125169"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yong-Oon Ahn, Matthew A Weeres, Marie-Luise Neulen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Immunol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/eji.201445213"}], "href": "https://doi.org/10.1002/eji.201445213"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26046454"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26046454"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Jae Yoon Han, Yoon Sook Kim, Gyeong Jae Cho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Altered gene expression of caspase-10, death receptor-3 and IGFBP-3 in preeclamptic placentas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cells (2006)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17085968"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17085968"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Taylor H Schreiber, Dietlinde Wolf, Maria Bodero, et al. "}, {"type": "b", "children": [{"type": "t", "text": "T cell costimulation by TNFR superfamily (TNFRSF)4 and TNFRSF25 in the context of vaccination."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.1200597"}], "href": "https://doi.org/10.4049/jimmunol.1200597"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22956587"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22956587"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Rafia S Al-Lamki, Jun Wang, Sathia Thiru, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of silencer of death domains and death-receptor-3 in normal human kidney and in rejecting renal transplants."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S0002-9440(10)63670-X"}], "href": "https://doi.org/10.1016/S0002-9440(10"}, {"type": "t", "text": "63670-X) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12875962"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12875962"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Min Zhou, Rui Liu, Dinglei Su, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TL1A increased the differentiation of peripheral Th17 in rheumatoid arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cytokine (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cyto.2014.04.007"}], "href": "https://doi.org/10.1016/j.cyto.2014.04.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24832108"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24832108"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Sebastian Bittner, Gertrud Knoll, Martin Ehrenschwender "}, {"type": "b", "children": [{"type": "t", "text": "Death receptor 3 signaling enhances proliferation of human regulatory T cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1873-3468.12632"}], "href": "https://doi.org/10.1002/1873-3468.12632"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28337757"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28337757"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Leng Wen, Li Zhuang, Xia Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M305833200"}], "href": "https://doi.org/10.1074/jbc.M305833200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12882979"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12882979"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Nicolas Porquet, Andrée Poirier, François Houle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-11-285"}], "href": "https://doi.org/10.1186/1471-2407-11-285"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21722370"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21722370"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Saet-Byul Oh, Chul Ju Hwang, Suk-Young Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Anti-cancer effect of tectochrysin in NSCLC cells through overexpression of death receptor and inactivation of STAT3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2014.07.007"}], "href": "https://doi.org/10.1016/j.canlet.2014.07.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25083589"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25083589"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "K Osawa, N Takami, K Shiozawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Death receptor 3 (DR3) gene duplication in a chromosome region 1p36.3: gene duplication is more prevalent in rheumatoid arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Immun (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.gene.6364097"}], "href": "https://doi.org/10.1038/sj.gene.6364097"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15241467"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15241467"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Eddie C Y Wang, Zarabeth Newton, Olivia A Hayward, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of early cartilage destruction in inflammatory arthritis by death receptor 3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arthritis Rheumatol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/art.38770"}], "href": "https://doi.org/10.1002/art.38770"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25044706"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25044706"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Sebastian Bittner, Gertrud Knoll, Simone Füllsack, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Soluble TL1A is sufficient for activation of death receptor 3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/febs.13576"}], "href": "https://doi.org/10.1111/febs.13576"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26509650"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26509650"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Sebastian Bittner, Gertrud Knoll, Martin Ehrenschwender "}, {"type": "b", "children": [{"type": "t", "text": "Death receptor 3 mediates necroptotic cell death."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Mol Life Sci (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00018-016-2355-2"}], "href": "https://doi.org/10.1007/s00018-016-2355-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27592300"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27592300"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Zhicheng Ge, Andrew J Sanders, Lin Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of death receptor-3 in human breast cancer and its functional effects on breast cancer cells in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2013.2259"}], "href": "https://doi.org/10.3892/or.2013.2259"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23443464"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23443464"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Giorgos Bamias, Eirini Filidou, Dimitris Goukos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Crohn's disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.trsl.2016.08.007"}], "href": "https://doi.org/10.1016/j.trsl.2016.08.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27665176"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27665176"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Fraser L Collins, Jessica O Williams, Anja C Bloom, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bone (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bone.2017.01.002"}], "href": "https://doi.org/10.1016/j.bone.2017.01.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28062298"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28062298"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Christopher W Borysenko, Verónica García-Palacios, Reed D Griswold, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Death receptor-3 mediates apoptosis in human osteoblasts under narrowly regulated conditions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.20812"}], "href": "https://doi.org/10.1002/jcp.20812"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16986165"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16986165"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Linda J Metheny-Barlow, Lu-Yuan Li "}, {"type": "b", "children": [{"type": "t", "text": "Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Semin Ophthalmol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/08820530500511446"}], "href": "https://doi.org/10.1080/08820530500511446"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16517446"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16517446"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Wei Wang, Ning Zhang, Xu-Hui Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of TL1A and DR3 in induction of ischaemia and inflammation in urinary bladder dysfunction in the elderly."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2012.928"}], "href": "https://doi.org/10.3892/mmr.2012.928"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22641456"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22641456"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Chiara Cavallini, Ornella Lovato, Anna Bertolaso, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.5201"}], "href": "https://doi.org/10.18632/oncotarget.5201"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26393680"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26393680"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Fraser L Collins, Jessica O Williams, Anja C Bloom, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2015/901679"}], "href": "https://doi.org/10.1155/2015/901679"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26065008"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26065008"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Peter Tougaard, Kristoffer Alexander Zervides, Søren Skov, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biologics beyond TNF-α inhibitors and the effect of targeting the homologues TL1A-DR3 pathway in chronic inflammatory disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunopharmacol Immunotoxicol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3109/08923973.2015.1130721"}], "href": "https://doi.org/10.3109/08923973.2015.1130721"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26810853"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26810853"}]}]}]}
|
| Synonyms | DR3, DDR3, LARD, TNFRSF12, PLEKHG5, APO-3, WSL-1, WSL-LR |
| Proteins | TNR25_HUMAN |
| NCBI Gene ID | 8718 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TNFRSF25 has 6,434 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 114 datasets.
Click the + buttons to view associations for TNFRSF25 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TNFRSF25 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of TNFRSF25 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TNFRSF25 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of TNFRSF25 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of TNFRSF25 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TNFRSF25 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving TNFRSF25 protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFRSF25 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TNFRSF25 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TNFRSF25 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of TNFRSF25 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TNFRSF25 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFRSF25 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with TNFRSF25 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TNFRSF25 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of TNFRSF25 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of TNFRSF25 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TNFRSF25 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing TNFRSF25 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing TNFRSF25 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with TNFRSF25 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TNFRSF25 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TNFRSF25 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with TNFRSF25 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with TNFRSF25 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with TNFRSF25 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by TNFRSF25 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with TNFRSF25 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TNFRSF25 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with TNFRSF25 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with TNFRSF25 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TNFRSF25 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TNFRSF25 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of TNFRSF25 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing TNFRSF25 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with TNFRSF25 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with TNFRSF25 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFRSF25 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with TNFRSF25 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing TNFRSF25 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of TNFRSF25 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TNFRSF25 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of TNFRSF25 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TNFRSF25 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TNFRSF25 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TNFRSF25 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving TNFRSF25 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving TNFRSF25 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving TNFRSF25 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing TNFRSF25 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing TNFRSF25 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by TNFRSF25 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by TNFRSF25 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by TNFRSF25 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of TNFRSF25 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TNFRSF25 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TNFRSF25 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TNFRSF25 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Guide to Pharmacology Protein Ligands of Receptors | ligands (protein) binding TNFRSF25 receptor from the curated Guide to Pharmacology Protein Ligands of Receptors dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFRSF25 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFRSF25 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of TNFRSF25 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TNFRSF25 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for TNFRSF25 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with TNFRSF25 gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with TNFRSF25 gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with TNFRSF25 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with TNFRSF25 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for TNFRSF25 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of TNFRSF25 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of TNFRSF25 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of TNFRSF25 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving TNFRSF25 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving TNFRSF25 protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TNFRSF25 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of TNFRSF25 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with TNFRSF25 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TNFRSF25 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of TNFRSF25 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of TNFRSF25 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TNFRSF25 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing TNFRSF25 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain TNFRSF25 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by TNFRSF25 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting TNFRSF25 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of TNFRSF25 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of TNFRSF25 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by TNFRSF25 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for TNFRSF25 from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of TNFRSF25 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for TNFRSF25 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TNFRSF25 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of TNFRSF25 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving TNFRSF25 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving TNFRSF25 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving TNFRSF25 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of TNFRSF25 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TNFRSF25 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TNFRSF25 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TNFRSF25 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TNFRSF25 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| SynGO Synaptic Gene Annotations | synaptic terms associated with TNFRSF25 gene from the SynGO Synaptic Gene Annotations dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of TNFRSF25 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of TNFRSF25 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of TNFRSF25 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of TNFRSF25 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of TNFRSF25 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TNFRSF25 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of TNFRSF25 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TNFRSF25 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with TNFRSF25 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TNFRSF25 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving TNFRSF25 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving TNFRSF25 protein from the WikiPathways Pathways 2024 dataset. | |